Imaging Findings of Patients Included in Study
18F-FDG PET/CT result | ||||||
Semiquantitative analysis (3D-SSP)* | ||||||
Cortical regions with significant metabolic change | ||||||
Patient no. | Antibody | Visual PET interpretation | Hypometabolism | Hypermetabolism | Interpretation | Brain MRI interpretation |
1 | Anti-NMDA | Abnormal | PAR (R, L), TMP (R), FRT (R, L), OCC (R, L) | — | Abnormal | Normal |
2 | Anti-NMDA | Abnormal | PAR (R, L), TMP (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Normal |
3 | Anti-NMDA | Abnormal | PAR (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Normal |
4 | Anti-NMDA | Abnormal | OCC (R) | — | Abnormal | Normal |
5 | Anti-NMDA | Abnormal | PAR (L), OCC (R, L) | — | Abnormal | Normal |
6 | Anti-VGKC | Abnormal | — | — | Normal | Normal |
7 | Anti-VGKC | Abnormal | PAR (R, L), TMP (L), FRT (R, L), OCC (L) | — | Abnormal | Abnormal |
8 | Anti-VGKC | Abnormal | PAR (R, L), FRT (R), OCC (R, L) | — | Abnormal | Normal |
9 | Anti-VGKC | Abnormal | PAR (R, L), TMP (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Abnormal |
10 | Anti-VGKC | Abnormal | PAR (R, L), TMP (R), FRT (R, L) | — | Abnormal | Abnormal |
11 | Anti-VGKC | Abnormal | PAR (L) | TMP (R), FRT (R), OCC (R) | Abnormal | Abnormal |
12 | Anti-Ma2 | Abnormal | PAR (L), TMP (L), FRT (L), OCC (R, L) | — | Abnormal | Abnormal |
13 | Anti-Ma2 | Abnormal | PAR (R, L), TMP (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Abnormal |
14 | Anti-Hu | Abnormal | PAR (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Normal |
15 | Anti-Hu | Abnormal | — | PAR (R, L), TMP (R, L), FRT (R, L), OCC (R, L) | Abnormal | Abnormal |
16 | Anti-Hu | Abnormal | FRT (R, L), OCC (R) | — | Abnormal | Normal |
17 | Anti-LGI1 | Abnormal | PAR (R, L), TMP (R, L), FRT (R, L), OCC (R, L) | — | Abnormal | Normal |
18 | Anti-LGI1 | Abnormal | PAR (R), TMP (R), FRT (R, L), OCC (R, L) | — | Abnormal | Abnormal |
19 | Anti-GAD65 | Abnormal | PAR (R, L), FRT (R) | — | Abnormal | Abnormal |
20 | Anti-GAD65 | Abnormal | PAR (R, L), FRT (R, L), OCC (L) | — | Abnormal | Normal |
21 | Anti-GAD65 | Abnormal | PAR (R, L), OCC (R) | — | Abnormal | Abnormal |
22 | Antiialpha3ACHR | Abnormal | OCC (R, L) | — | Abnormal | Normal |
23 | Anti-alpha3ACHR | Abnormal | PAR (R, L), TMP (R, L), FRT (R, L), OCC (L) | — | Abnormal | Normal |
↵* Average z score > 2 (2-tail P = 0.05) was considered as significant metabolic change. Bold regions represent areas with higher absolute z scores (absolute z > 2.58, 2-tail P = 0.01).
3D-SSP = 3D stereotactic surface projections; PAR = parietal cortex; TMP = temporal lobe; OCC = occipital lobe; FRT = frontal lobe.